Marwyn Value Investors Ltd (GB:MVI)
LSE:MVI
Top Page
Marwyn Value Investors
(LSE:MVI)
Select Model
Select Model
Rating:82Outperform
Price Target:
161.00 p
▲(20.15% Upside)
Action:N/ADate:01/04/26
The score is driven primarily by a very strong, low-debt balance sheet and solid cash generation, supported by an attractive valuation (low P/E and high dividend yield). Technicals are constructive with price above key moving averages and positive MACD, while the main risk remains volatility in revenue and earnings.
Marwyn Value Investors (MVI) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
N/A
Dividend Yield4.96%
Average Volume (3M)138.84K
Price to Earnings (P/E)1.1
Beta (1Y)0.34
Revenue GrowthN/A
EPS GrowthN/A
CountryUK
Employees11
SectorFinancial
Sector Strength70
IndustryAsset Management
Share Statistics
EPS (TTM)0.26
Shares Outstanding55,850,840
10 Day Avg. Volume40,558
30 Day Avg. Volume138,843
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.45
Price to Sales (P/S)2.79
P/FCF Ratio10.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Marwyn Value Investors Business Overview & Revenue Model
Company Description
Marwyn Value Investors Limited specializes in investments in growth capital, buyout, industry consolidation, and acquisition-led growth strategies in small and mid-cap businesses. The fund also invests in consolidation opportunities in industry se...
How the Company Makes Money
null...
Marwyn Value Investors Financial Statement Overview
Summary
Income Statement
72
Positive
Balance Sheet
90
Very Positive
Cash Flow
77
Positive
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Jun 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 18.67M | 4.87M | 2.05M | 16.89M | -1.20M |
| Gross Profit | 18.67M | 4.87M | 2.05M | 16.89M | -1.20M |
| EBITDA | 18.67M | -3.43K | 2.05M | 19.09M | -1.20M |
| Net Income | 18.67M | 4.86M | 2.05M | 19.09M | -1.20M |
Balance Sheet | |||||
| Total Assets | 115.03M | 101.38M | 102.42M | 105.40M | 97.73M |
| Cash, Cash Equivalents and Short-Term Investments | 140.04K | 133.99K | 129.15K | 128.55K | 128.61K |
| Total Debt | 125.00K | 125.00K | 125.00K | 125.00K | 125.00K |
| Total Liabilities | 140.04K | 133.99K | 125.00K | 125.00K | 125.00K |
| Stockholders Equity | 114.89M | 101.24M | 102.29M | 105.27M | 97.60M |
Cash Flow | |||||
| Free Cash Flow | 5.03M | 5.91M | 5.03M | 11.42M | 836.98K |
| Operating Cash Flow | 5.03M | 5.91M | 5.03M | 11.42M | 836.98K |
| Investing Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | -5.03M | -5.91M | -5.03M | -11.42M | -836.74K |
Marwyn Value Investors Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ― | 1.10 | ― | 4.96% | ― | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | £18.85M | 4.02 | 16.48% | ― | -79.36% | 78.16% | |
48 Neutral | £1.45M | -2.93 | -37.63% | ― | -100.66% | 84.15% | |
48 Neutral | £4.38M | -1.85 | -12.33% | ― | ― | ― | |
44 Neutral | £14.09M | -19.81 | -21.85% | ― | ― | ― | |
40 Underperform | $1.02M | -0.04 | ― | ― | -96.59% | 93.69% |
* Financial Sector Average
GB:MVI
Marwyn Value Investors
134.00
34.85
35.15%
GB:JADE
Jade Road Investments
0.43
-2.10
-83.18%
GB:TRUE
Braveheart Investment
1.85
-3.15
-63.00%
GB:MAFL
Mineral & Financial Investments
48.50
27.00
125.58%
GB:PRIM
Primorus Investments
3.50
-0.15
-4.11%
GB:450
Marwyn Acquisition Company PLC
2.10
0.00
0.00%
Marwyn Value Investors Corporate Events
Dividends
Marwyn Value Investors Declares Interim Dividend for Ordinary Shareholders
Positive
Jan 29, 2026
Marwyn Value Investors Limited has declared an interim dividend of 2.265p per ordinary share, to be paid on 27 February 2026 under its ordinary share distribution policy. The dividend will be settled electronically via CREST or BACS, with an ex-di...
Other
Marwyn Director Moves Shares Between Broker Accounts With No Change in Holding
Neutral
Jan 8, 2026
Marwyn Value Investors Limited disclosed that independent non-executive director Peter Rioda has transferred 10,000 ordinary shares between his own broker accounts, a move that does not alter his overall beneficial holding in the company, which re...
Regulatory Filings and Compliance
Marwyn Employees Increase Stake as CIO Corsellis’ Holding Rises to 12.3%
Positive
Dec 23, 2025
Marwyn Value Investors has disclosed that Marwyn employees have purchased 37,761 ordinary shares in the company from Marwyn Capital Management Limited at 135.69p per share, matching MCML’s original acquisition cost in October. Following the ...
Other
Marwyn Director Peter Rioda Increases Stake with Additional Share Purchase
Positive
Dec 18, 2025
Marwyn Value Investors has disclosed that independent non-executive director Peter Rioda has increased his stake in the company by purchasing 10,000 ordinary shares at a price of £1.3807 per share. Following the transaction, executed on the L...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.